This activity will review key predictors for hyperkalemia, clinical evidence for new potassium-binding agents, and the use of team-based care in rural and underserved areas.

Faculty discuss the case of a man with obesity and obstructive sleep apnea, with a focus on the interplay between the two conditions, as well as weight loss to relieve symptoms.

 Describe the pathophysiological basis for symptom development in XLH and TIO

 Review current treatment guidelines for the reduction of CVD risk in patients with T2D

Individualize GLP-1 RA selection based on patient presentation and preference, including needs for glucose reduction, cardiovascular risk, weight, administration route, and frequency (Modules 1, 2, 3 & 5)

Review data related to an improved understanding of the impact of GLP-1 RAs on kidney health and other microvascular outcomes (Modules 4 & 5)

List recommended diagnostic practices for CKD in patients with T2D and elaborate on the relationship between CKD and cardiovascular and renal outcomes

Neuroendocrine tumors are often misdiagnosed as irritable bowel syndrome and other diseases. They can also be found incidentally by colonoscopy, EGD, or CT scan.